As we all know that cancer is the major health issue and the leading cause of death across the globe, as many researchers have studies on how to stop these deadly diseases in its tracks. However, it has been found that nearly 1 in 6 deaths are down to cancer. In the recent studies from the national cancer institute have found that there were 1,688,780 new cancer cases and 6, 00,920 cancer related death in 2018. Moreover, the most common types of cancer diseases treatments are chemotherapy, radiotherapy, tumor surgery, and in the case prostate cancer and breast cancer, there is hormonal therapy.
Although, some other types of treatment are beginning to pick up steam that is therapies which is the combination with the other treatments that are also meant to help defeat cancer more efficiently and ideally have fewer side effects. However, some innovations in cancer treatment might aim to address a set of issues which will typically face healthcare providers as well as patients that includes aggressive treatment accompanied by unwanted side effects, tumor recurrence after the treatment, surgery or both aggressive cancers which are resilient to widely utilized treatments.
Boosting the immune system's arsenal
Not surprisingly, one of the types of therapy which has attracted a lot of attention recently among the people which is immunotherapy, which aims to reinforce our own bodies' existing arsenal against foreign bodies and harmful cells: our immune system's response to the spread of cancer tumors. Besides, in respect of many types of cancer cell some of them are so dangerous because they have ways of "duping" the immune system that might be either into ignoring them altogether or else into giving them a "helping hand."
These are some types of aggressive cancer that are able to spread more easily and become resistant to chemotherapy or radiotherapy. But, thanks to in vitro and in vivo experiments, as the researchers are now learning how they would be able to deactivate the cancer bacteria or cells' protective systems. Though, one of the recent studies published last year in nature immunology found that macrophages, or white blood cells, which are normally tasked with eating up cellular debris and other harmful foreign objects are failed to obliterate the super-aggressive cancer cells.
Today, there are many emerging researches which are promising more effective treatments, while most of these projects/treatments are still in their early stages, which are still conducted in vitro and in vivo experiments. Moreover, some of the potential treatments still have a long way to go before clinical trials in human patients. But, that doesn't mean we should lose all hope because some of the most popular researchers explain that these efforts should make the person optimistic.